Pangea Biomed

Pangea Biomed is at the forefront of biotechnology research, redefining precision oncology to expand the number of patients benefiting from advanced cancer treatments. Leveraging the hidden power of RNA sequencing combined with machine learning-enabled network effects, Pangea Biomed's ENLIGHT platform reveals critical biological insights. This innovative approach pinpoints the most effective strategies for combating cancer, marking a significant advancement in personalized medicine.

Located in Tel Aviv, IL, Pangea Biomed is dedicated to increasing the effectiveness of immunotherapy and precision oncology. While these treatments have offered hope for decades, Pangea Biomed is committed to making them accessible to a greater percentage of cancer patients through cutting-edge research and development. The company’s focus on innovation aims to transform the landscape of cancer treatment.

Pangea Biomed's commitment to improving patient outcomes drives its ongoing research and development efforts. The ENLIGHT platform represents a significant step forward in precision oncology, offering the potential to tailor treatments more effectively to individual patient needs. We invite the management team at Pangea Biomed to further showcase their unique capabilities and product offerings by creating a customized and exclusive company showcase on our platform.